BA
TARA icon

BlackRock Advisors’s Protara Therapeutics TARA Stock Holding History

BlackRock Advisors’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$3K Hold
34
– – ﹤0.01% 3664
2016
Q3 		$13K Hold
34
– – ﹤0.01% 3534
2016
Q2 		$11K Sell
34
-50
-60% -$15K ﹤0.01% 3565
2016
Q1 		$26K Hold
84
– – ﹤0.01% 3370
2015
Q4 		$52K Sell
84
-43
-34% -$25.2K ﹤0.01% 3177
2015
Q3 		$71K Buy
127
+13
+11% +$8.05K ﹤0.01% 3220
2015
Q2 		$81K Buy
+114
New +$70.5K ﹤0.01% 3227

Other funds holding TARA

A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PI
Pharmstandard International Luxembourg $29M AUM 3.25% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
FCI
Financial Counselors Inc Overland Park, Kansas $70.9M AUM 16.78% 1-Year Est. Return

BlackRock Advisors's TARA Position: Q4 2016 in Review

BlackRock Advisors held its Protara Therapeutics (TARA) position steady in Q4 2016 at 34 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #3664.

BlackRock Advisors first reported a position in TARA in Q2 2015 and has held it in 7 quarters since. The position peaked at $81K in Q2 2015. 25 funds tracked by Wall St. Rank hold TARA as of Q4 2016.

  • BlackRock Advisors held 34 shares of Protara Therapeutics worth $3K as of Q4 2016.
  • BlackRock Advisors left its Protara Therapeutics share count unchanged in Q4 2016.
  • Protara Therapeutics made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3664 holding.
  • BlackRock Advisors first reported a position in Protara Therapeutics in Q2 2015 and has held it in 7 quarters since.
  • BlackRock Advisors's Protara Therapeutics position peaked at $81K in Q2 2015.
  • 25 funds tracked by Wall St. Rank held Protara Therapeutics as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.